InvestorsHub Logo
Followers 14
Posts 737
Boards Moderated 0
Alias Born 09/13/2013

Re: None

Thursday, 12/10/2015 10:37:30 AM

Thursday, December 10, 2015 10:37:30 AM

Post# of 1047
http://www.wallstreetscope.com/investigation-for-investors-in-shares-of-celladon-corp-nasdaqcldn-over-acquisition-announced/25531436/


Investigation for Investors in shares of Celladon Corp (NASDAQ:CLDN) over Acquisition announced

The takeover of Celladon is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold NASDAQ:CLDN shares concerning whether the takeover of Celladon Corp. is unfair to NASDAQ:CLDN stockholders.

Investors who purchased shares of Celladon Corp (NASDAQ:CLDN) and currently hold any of those NASDAQ:CLDN shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm concerns whether certain officers and directors of Celladon Corp breached their fiduciary duties owed to NASDAQ:CLDN investors in connection with the proposed acquisition.

On November 18, 2015 Celladon Corp (NASDAQ:CLDN) and Eiger BioPharmaceuticals, Inc., a privately-held biopharmaceutical company, today announced that they have entered into a merger agreement under which the stockholders of Eiger would become the majority owners of Celladon, and the operations of Celladon and Eiger would be combined.